Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- JP Morgan analyst Jessica Fye initiated coverage on Aktis Oncology Inc (NASDAQ:AKTS) with an Overweight rating and announced a price target of $30. Aktis Oncology shares closed at $21.98 on Monday. See how other analysts view this stock.
- Leerink Partners initiated coverage on Aktis Oncology (NASDAQ:AKTS) with an Outperform rating and announced a price target of $31. Aktis Oncology shares closed at $21.98 on Monday. See how other analysts view this stock.
- Seaport Global analyst David Joyce initiated coverage on GCI Liberty Inc (NASDAQ:GLIBK) with a Buy rating and announced a price target of $68. GCI Liberty shares closed at $37.34 on Monday. See how other analysts view this stock.
Considering buying GLIBK stock? Here’s what analysts think:
Photo via Shutterstock
Recent Comments